GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (LSE:AMS) » Definitions » Enterprise Value

Advanced Medical Solutions Group (LSE:AMS) Enterprise Value : £373.8 Mil (As of May. 06, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Advanced Medical Solutions Group Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Advanced Medical Solutions Group's Enterprise Value is £373.8 Mil. Advanced Medical Solutions Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £22.7 Mil. Therefore, Advanced Medical Solutions Group's EV-to-EBIT ratio for today is 16.49.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Advanced Medical Solutions Group's Enterprise Value is £373.8 Mil. Advanced Medical Solutions Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was £33.5 Mil. Therefore, Advanced Medical Solutions Group's EV-to-EBITDA ratio for today is 11.17.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Advanced Medical Solutions Group's Enterprise Value is £373.8 Mil. Advanced Medical Solutions Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £126.2 Mil. Therefore, Advanced Medical Solutions Group's EV-to-Revenue ratio for today is 2.96.


Advanced Medical Solutions Group Enterprise Value Historical Data

The historical data trend for Advanced Medical Solutions Group's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Medical Solutions Group Enterprise Value Chart

Advanced Medical Solutions Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 581.81 480.89 667.21 489.34 399.93

Advanced Medical Solutions Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 667.21 573.14 489.34 430.84 399.93

Competitive Comparison of Advanced Medical Solutions Group's Enterprise Value

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Enterprise Value falls into.



Advanced Medical Solutions Group Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Advanced Medical Solutions Group's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Advanced Medical Solutions Group's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Medical Solutions Group  (LSE:AMS) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Advanced Medical Solutions Group's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=373.801/22.668
=16.49

Advanced Medical Solutions Group's current Enterprise Value is £373.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £22.7 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Advanced Medical Solutions Group's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=373.801/33.456
=11.17

Advanced Medical Solutions Group's current Enterprise Value is £373.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was £33.5 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Advanced Medical Solutions Group's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=373.801/126.21
=2.96

Advanced Medical Solutions Group's current Enterprise Value is £373.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Advanced Medical Solutions Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £126.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Medical Solutions Group Enterprise Value Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Medical Solutions Group (LSE:AMS) Business Description

Traded in Other Exchanges
Address
Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.